Harith Rajagopalan
CIK: 0001667672
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FRACTYL HEALTH, INC.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 10, 2026GUTS
FRACTYL HEALTH, INC.
Purchase(P)Direct25K shares at avg. $0.73$18K - Dec 15, 2025GUTS
FRACTYL HEALTH, INC.
Award(A)DirectStock Option (right to buy)
2.5M shares- - Dec 4, 2025GUTS
FRACTYL HEALTH, INC.
Purchase(P)Direct10.4K shares at avg. $1.92$20K - Feb 27, 2025GUTS
FRACTYL HEALTH, INC.
Award(A)DirectStock Option (right to buy)
261.5K shares- - Feb 27, 2025GUTS
FRACTYL HEALTH, INC.
Award(A)DirectStock Option (right to buy)
571.5K shares- - Jan 31, 2025GUTS
FRACTYL HEALTH, INC.
Exercise(M)Direct91K shares at avg. $1.70$155K - Jan 31, 2025GUTS
FRACTYL HEALTH, INC.
Sale(S)Direct91K shares at avg. $1.82$165K - Jan 30, 2025GUTS
FRACTYL HEALTH, INC.
Exercise(M)Direct20.9K shares at avg. $1.70$36K - Jan 30, 2025GUTS
FRACTYL HEALTH, INC.
Sale(S)Direct20.9K shares at avg. $1.95$41K - Nov 11, 2024GUTS
FRACTYL HEALTH, INC.
Sale(S)Direct96.5K shares at avg. $2.47$238K - Nov 10, 2024GUTS
FRACTYL HEALTH, INC.
Exercise(M)Direct216.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | GUTS FRACTYL HEALTH, INC. | Purchase(P) | 25,000 | $0.73 | $18,253 | Direct |
| Dec 15, 2025 | GUTS FRACTYL HEALTH, INC. | Award(A) Stock Option (right to buy) | 2,486,302 | - | - | Direct |
| Dec 4, 2025 | GUTS FRACTYL HEALTH, INC. | Purchase(P) | 10,416 | $1.92 | $19,999 | Direct |
| Feb 27, 2025 | GUTS FRACTYL HEALTH, INC. | Award(A) Stock Option (right to buy) | 261,540 | - | - | Direct |
| Feb 27, 2025 | GUTS FRACTYL HEALTH, INC. | Award(A) Stock Option (right to buy) | 571,491 | - | - | Direct |
| Jan 31, 2025 | GUTS FRACTYL HEALTH, INC. | Exercise(M) | 90,972 | $1.70 | $154,652 | Direct |
| Jan 31, 2025 | GUTS FRACTYL HEALTH, INC. | Sale(S) | 90,972 | $1.82 | $165,205 | Direct |
| Jan 30, 2025 | GUTS FRACTYL HEALTH, INC. | Exercise(M) | 20,948 | $1.70 | $35,612 | Direct |
| Jan 30, 2025 | GUTS FRACTYL HEALTH, INC. | Sale(S) | 20,948 | $1.95 | $40,798 | Direct |
| Nov 11, 2024 | GUTS FRACTYL HEALTH, INC. | Sale(S) | 96,517 | $2.47 | $238,358 | Direct |
| Nov 10, 2024 | GUTS FRACTYL HEALTH, INC. | Exercise(M) | 216,924 | - | $0 | Direct |
1-11 of 11 transactions
About Rajagopalan Harith
Rajagopalan Harith (SEC CIK 0001667672) files insider reports with the SEC as Chief Executive Officer of FRACTYL HEALTH, INC. (GUTS).
Signal8 holds 6 ownership filings by Rajagopalan Harith, all Form 4s, filed between Nov 13, 2024 and Jun 11, 2026. Those filings report 11 transactions, from Nov 10, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rajagopalan Harith's filings is in BURLINGTON, MA.
Recent filings by Rajagopalan Harith
- Jun 10, 2026: Open-market purchase of GUTS shares (Form 4, code P).
- Dec 15, 2025: Grant or award of GUTS derivative securities (Form 4, code A).
- Dec 4, 2025: Open-market purchase of GUTS shares (Form 4, code P).
- Feb 27, 2025: Grants or awards of GUTS derivative securities (2 lines, Form 4, code A).
- Jan 31, 2025: Option exercise of GUTS shares (Form 4, code M).
Other insiders filing for FRACTYL HEALTH, INC. (GUTS)
- BRADLEY WILLIAM, Director
- Royan Ajay, Director
- Conaway Samuel, Director
- Thompson Christopher Charles, Director
- Elia Marc, Director
- Barnes Kelly Ann, Director